Applied DNA Sciences Inc. (APDN)
| Bid | 4.6 |
| Market Cap | 2.4M |
| Revenue (ttm) | 3.79M |
| Net Income (ttm) | -31.28M |
| EPS (ttm) | 3730.95 |
| PE Ratio (ttm) | n/a |
| Forward PE | -0.06 |
| Analyst | Buy |
| Ask | 4.7 |
| Volume | 57,282 |
| Avg. Volume (20D) | 105,296 |
| Open | 4.60 |
| Previous Close | 4.94 |
| Day's Range | 4.54 - 4.85 |
| 52-Week Range | 4.35 - 2655.00 |
| Beta | 0.05 |
About APDN
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for APDN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago · accessnewswire.com
Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. HaywardPresident and COO Judy Murrah Appointed New Chairperson of the Board of Directors and CEO STONY BROOK, NY / ACCESS Newswire / June 17, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or...
1 month ago · accessnewswire.com
Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effec...
1 month ago · accessnewswire.com
Applied DNA Reports Second Quarter Fiscal 2025 Financial Results- Therapeutic DNA Production Services Segment (LineaRx) Revenues Up 44% Y/Y, Contributing to a 6% Increase in Total Revenues - - Intra-Quarter Investor Conference Call and Webcast Scheduled for June ...
2 months ago · accessnewswire.com
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price RequirementSTONY BROOK, NY / ACCESS Newswire / April 8, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced that on April 7, 2025, it received a...